Biotech Company - Serum Institute of India (Serum) has hiked its stake in Chennai-based global pharma major - Orchid Chemicals & Pharmaceuticals (Orchid). The institute has bought 5 lakh fresh shares for Rs 6.6 crore through open market transactions, according to the data available with the exchange. As on September 30, Serum Institute held 2,529,197 shares or 3.59 percent stake in Orchid.
Serum Institute of India was founded with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. It has established itself as the world's largest producer of Measles and DTP group of vaccines. It is estimated that two out of every three children immunized in the world is vaccinated by a vaccine manufactured by Serum Institute.
Orchid is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |